Rituximab and intravenous immune globulin for desensitization during renal transplantation. - Wikidata - awgldk - TriplyDB

Rituximab and intravenous immune globulin for desensitization during renal transplantation.

Rituximab and intravenous immune globulin for desensitization during renal transplantation.

http://www.wikidata.org/entity/Q46477840

about

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients Monoclonal antibody therapy and renal transplantation: focus on adverse effects Biologics in organ transplantation Immunologic considerations in heart transplantation for congenital heart disease Biologics in renal transplantation Modern approaches to incompatible kidney transplantation Treatment options and strategies for antibody mediated rejection after renal transplantation Issues in solid-organ transplantation in children: translational research from bench to bedside.Rituximab in renal transplantation B cell repertoires in HLA-sensitized kidney transplant candidates undergoing desensitization therapy Incompatible live-donor kidney transplantation in the United States: results of a national survey Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Approach to the Highly Sensitized Kidney Transplant Candidate.Desensitization: Overcoming the Immunologic Barriers to Transplantation Therapeutic apheresis before and after kidney transplantation.The role of therapeutic apheresis in high immunologic risk renal transplantation: a review of current trends.Use of monoclonal antibodies in renal transplantation.Antibody desensitization therapy in highly sensitized lung transplant candidates.Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients.Autoimmunity as a predisposition for infectious diseases Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centers Rituximab for non-Hodgkin's lymphoma: a story of rapid success in translation.Diagnosis and management of antibody-mediated rejection: current status and novel approaches.IVIg treatment reduces catalytic antibody titers of renal transplanted patients A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation.Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic Opportunity Utility of HLA Antibody Testing in Kidney Transplantation.Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation.Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant Candidates Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates Tolerogenic therapies in transplantation.Assessment of variation in live donor kidney transplantation across transplant centers in the United States.

P2860

Q26774993-FF467169-2445-420F-86DB-3C3058F911C4 Q26826880-6E326631-A211-4488-9450-530E5EF68D89 Q26829578-AF7F2D79-8051-4DC5-9B32-D647E8A0B917 Q26995790-45BDF98E-1AF3-4377-8EC7-81D6126627B0 Q27009997-C6D52D30-19D7-48B7-B38F-58DB78DA39E0 Q27010224-D81F169A-A43B-41D3-80C5-0EBE050910E5 Q27021397-941AA705-B21A-4353-9975-A0759CCE60EB Q27023312-52B832B2-129D-46E2-B0BB-6B59170F69CB Q27026434-65A5F687-769B-4BE8-B941-6D45E8A6F74A Q28563989-1F48F996-1E70-419A-8494-34CCE314154E Q28741418-FCACDD11-D47A-4094-813E-904CB5A1A31C Q30276550-C64423B0-7035-4569-90A0-470164B9BCCB Q30277267-6658A7F9-C930-4C56-8FAE-52ED9A195468 Q30397952-10183733-06A0-46CF-8611-4D98ACC9E98C Q30454250-102DD9EA-EE2A-4C5F-B712-76F435D5EC0B Q30455087-3E1C1C72-11EE-4642-982E-925CC40451BB Q33396236-3FA5CCC4-C587-42A9-9A08-2AD5F4057BB6 Q33414196-A46D0390-5A26-4C9C-B4C6-9E6A6564D4EB Q33560520-50E7F0D2-A618-4BFB-BB6D-73631EFA923E Q33747588-E88FBA5D-39D3-4151-ADC3-295BD459C2EF Q33755443-2014A0A9-5216-4274-9BA2-9F7396E9E48A Q33842250-AE99512D-E050-4D2C-9403-94C9061C5EC6 Q33988125-4E14EC37-66B9-422F-BC54-D1EBBB7CF8ED Q34124202-CC093259-C43F-4A72-999E-658DFCCED8B3 Q34159016-2BE0772C-B14A-4153-A0A1-1C845017C0D6 Q34398374-EB20F282-24A7-4143-BFBE-08A1C94678AC Q34687563-B06B62E9-5023-4F3E-B2C2-EAC176F1EF01 Q34841849-52E304AF-37E8-47AA-AE15-F535DFA2FC4D Q34962680-8960268C-CFFD-4C89-AF5E-0B9D87675916 Q35008036-123967EB-73F0-404C-A8D3-8850CDC26781 Q35664634-932AB6D8-4C45-4836-A7B6-BC2E6115CABA Q35692718-760FA89A-F480-4500-844A-21FFFC195C12 Q35790601-ACF83D50-3E5D-482E-82CE-A4622EF42465 Q35874401-218D52BE-D18C-4C84-B54B-769B5D08023B Q35885244-2331048F-B08F-4EFD-8B85-B3065B7D8501 Q35911619-12EBDFB4-EEF9-4E7A-9A26-4BEAA672AB29 Q35990094-29265A0C-3121-4E90-A1AD-3D9807FA3B2B Q36053023-FA1137B6-FF72-41E2-90D9-42B3D78CA82B Q36102133-E36D9B3C-9250-4674-90DE-AE47EC3351A6 Q36292000-4006FDDE-9C88-4888-BCDA-4339434D0C1C

P2860

Rituximab and intravenous immune globulin for desensitization during renal transplantation.

http://www.wikidata.org/entity/Q46477840

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Rituximab and intravenous immu ...... during renal transplantation.

@en

Rituximab and intravenous immu ...... during renal transplantation.

@nl

type

label

Rituximab and intravenous immu ...... during renal transplantation.

@en

Rituximab and intravenous immu ...... during renal transplantation.

@nl

prefLabel

Rituximab and intravenous immu ...... during renal transplantation.

@en

Rituximab and intravenous immu ...... during renal transplantation.

@nl

P1433

Q46477840-C962DBB8-63FB-4D2B-885D-53907F1C4F86

P1476

Q46477840-37137EB5-343E-489C-8F27-3A8DA070375F

P2093

Q46477840-05FE2D43-20A5-42E4-B925-2FDEF12E2D20

Q46477840-577AEBEC-F5BB-497B-89F6-DCD8790ACE39

Q46477840-5D565021-A59F-4241-8EF9-BD53E62F2961

Q46477840-6574ABAA-519D-48CD-9CA2-BB46591CB150

Q46477840-A713072F-8383-408D-B7C1-657B28EDFA66

Q46477840-AEBB6CEA-92A3-4B4A-9BEC-E3BC6069D4F1

Q46477840-B1974942-CF86-412B-B55F-5F84068A184E

Q46477840-EAC979CD-3E16-4D61-AECA-8C9CAB8F3856

Q46477840-F7885455-1A42-4542-90B5-DF9A84851EFC

P304

Q46477840-EFBFE667-17FF-4C1D-B5AB-75A87792D536

P31

Q46477840-C20CE9E5-423E-499B-A831-2E72AC42218D

P356

Q46477840-D3D957CC-876B-473F-8541-4C9A6CB2EEF7

P407

Q46477840-62678AA2-4DB0-45DB-946C-0C21FB36ABBD

P433

Q46477840-97E98C85-481C-4548-9386-E3C21FE06071

P478

Q46477840-7BA80940-AC95-403C-BF8D-7144C11A181E

P577

Q46477840-43A6F423-4174-4D11-B7FD-F3AC839B824C

P698

Q46477840-0E83FFCD-400D-43ED-98BE-3E12EBB3C781

P356

P1433

The New England Journal of Medicine

P1476

Rituximab and intravenous immu ...... during renal transplantation.

@en

P2093

Alice Peng

http://www.w3.org/2001/XMLSchema#string

Ashley A Vo

http://www.w3.org/2001/XMLSchema#string

Chih-Hung Lai

http://www.w3.org/2001/XMLSchema#string

Jennifer Wang

http://www.w3.org/2001/XMLSchema#string

Marina Lukovsky

http://www.w3.org/2001/XMLSchema#string

Mieko Toyoda

http://www.w3.org/2001/XMLSchema#string

Nancy L Reinsmoen

http://www.w3.org/2001/XMLSchema#string

Rafael Villicana

http://www.w3.org/2001/XMLSchema#string

Stanley C Jordan

http://www.w3.org/2001/XMLSchema#string

P304

242-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0707894

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

359

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18635429

http://www.w3.org/2001/XMLSchema#string